ライフサイエンスコーパス: methicillin-resistant S. aureus

1 obactam for P. aeruginosa and vancomycin for methicillin-resistant S. aureus).

2 methicillin-sensitive S. aureus) and RN450M (methicillin-resistant S. aureus).

3 wn CF pathogens, including P. aeruginosa and methicillin-resistant S. aureus.

4 al cellulitis caused by community-associated methicillin-resistant S. aureus.

5 enged with virulent methicillin-sensitive or methicillin-resistant S. aureus.

6 eus infections, particularly those involving methicillin-resistant S. aureus.

7 ion of the antibiotic-resistant phenotype in methicillin-resistant S. aureus.

8 was able to rapidly and accurately diagnose methicillin-resistant S. aureus.

9 of which is complicated by the emergence of methicillin-resistant S. aureus.

10 stinguishable from that of hospital-acquired methicillin-resistant S. aureus.

11 ibiotic susceptibility of community-acquired methicillin-resistant S. aureus.

12 e toxin 1, in both methicillin-sensitive and methicillin-resistant S. aureus.

13 ed bacteremia, right-sided endocarditis, and methicillin-resistant S. aureus.

14 lure in 2 patients with osteomyelitis due to methicillin-resistant S. aureus.

15 nt of nosocomial pneumonia in the absence of methicillin-resistant S. aureus.

16 l when there is extranasal colonization with methicillin-resistant S. aureus.

17 ratitis mediated by methicillin-sensitive or methicillin-resistant S. aureus.

18 od susceptibility against ciprofloxacin- and methicillin-resistant S. aureus.

19 ssay for PBP2a using membranes prepared form methicillin-resistant S. aureus.

20 Those strains of epidemic methicillin-resistant S. aureus 16 (EMRSA-16) studied al

21 e patients (15%) (4 Staphylococcus aureus [3 methicillin-resistant S. aureus], 2 Stenotrophomonas mal

22 hylococcus aureus (11.5% vs 0.8%, P < .001); methicillin-resistant S. aureus (6.9% vs 0%, P = .003);

23 the clinical cure rates in ME patients with methicillin-resistant S. aureus ABSSSIs were 142 of 152

24 In methicillin-resistant S. aureus, addition of oxacillin d

25 e groups of BALB/c mice were inoculated with methicillin-resistant S. aureus American Type Culture Co

26 cultures demonstrated that identification of methicillin resistant S. aureus and vancomycin resistant

27 Of the 165 isolates, 117 were methicillin-resistant S. aureus and 48 were methicillin-

28 tant, prompting hospital-based screening for methicillin-resistant S. aureus and implementation of bo

29 he most potent MP against Y. enterocolitica, methicillin-resistant S. aureus and M. smegmatis was gal

30 d peritoneal macrophage phagocytosis of both methicillin-resistant S. aureus and methicillin-sensitiv

31 gainst early and mature biofilms produced by methicillin-resistant S. aureus and methicillin-suscepti

32 cific, and reproducible for the detection of methicillin-resistant S. aureus and yields complete resu

33 a DNA segment in the hypervariable region of methicillin-resistant S. aureus (and also similar to the

34 ty against extended-spectrum beta-lactamase, methicillin-resistant S. aureus, and carbapenem-resistan

35 of S. caprae, emphasize its similarities to methicillin-resistant S. aureus, and demonstrate its abi

36 ltidrug-resistant bacteria, Candida species, methicillin-resistant S. aureus, and P. aeruginosa would

37 al, hematologic, or hepatic), infection with methicillin-resistant S. aureus, and TTPs of </=12 h wer

38 organisms predominate, whereas anaerobes and methicillin-resistant S. aureus are significant predicto

39 addition, multidrug-resistant organisms like methicillin-resistant S.aureus are spreading from health

40 nds, including cephalosporins active against methicillin-resistant S. aureus, are in preclinical deve

41 surveillance culture can accurately exclude methicillin-resistant S. aureus as an etiology in most p

42 itivity (0.32; 95% CI, 0.20-0.48) to predict methicillin-resistant S. aureus-associated infections, w

43 ty/specificity of colonization in predicting methicillin-resistant S. aureus-associated infections.

44 ne fourth of patients who are colonized with methicillin-resistant S. aureus at admission to the ICU.

45 ients, 5.8-8.3% of patients are colonized by methicillin-resistant S. aureus at admission, with a sig

46 he mechanisms by which S. aureus - including methicillin-resistant S. aureus - avoids neutrophil-medi

47 aureus isolate occurred during treatment of methicillin-resistant S. aureus bacteremia and probable

48 esistant S. aureus infection and eliminating methicillin-resistant S. aureus bacteremia in the ICU wi

49 over the last 5 years, not a single case of methicillin-resistant S. aureus bacteremia was observed.

50 MIC) has been shown to affect the outcome of methicillin-resistant S. aureus bacteremia, and recent d

51 weeks of vancomycin treatment for recurrent methicillin-resistant S. aureus bacteremia.

52 Moreover, with community-associated methicillin-resistant S. aureus (CA MRSA) in a mouse mod

53 The dominant community-associated methicillin-resistant S. aureus (CA-MRSA) clone, USA300,

54 Community-associated methicillin-resistant S. aureus (CA-MRSA) is the most co

55 sent in almost all USA300 community-acquired methicillin-resistant S. aureus (CA-MRSA) isolates.

56 In community-associated methicillin-resistant S. aureus (CA-MRSA) strain MW2, no

57 isolates of S. aureus, community-associated methicillin-resistant S. aureus (CA-MRSA) USA300 secrete

58 a DeltahysA mutant of a community-associated methicillin-resistant S. aureus (CA-MRSA) USA300 strain

59 ar peptides produced by community-associated methicillin-resistant S. aureus (CA-MRSA) with homology

60 iologically linked with community-associated methicillin-resistant S. aureus (CA-MRSA), has frequentl

61 to the USA-300 group of community-associated methicillin-resistant S. aureus (CA-MRSA).

62 t S. aureus (HA-MRSA) and community-acquired methicillin-resistant S. aureus (CA-MRSA).

63 the rapid emergence of community-associated methicillin-resistant S. aureus (CA-MRSA).

64 Methicillin-resistant S. aureus clinical specimens were

65 6538, Listeria monocytogenes ATCC 13932 and methicillin-resistant S. aureus clinical strains.

66 fected with Staphylococcus aureus, including methicillin-resistant S. aureus, clinical success was se

67 reen for GISA among 630 clinical isolates of methicillin-resistant S. aureus collected during 1997 fr

68 us aureus (hVISA) among clinical isolates of methicillin-resistant S. aureus collected from three hos

69 The sensitivity and specificity of prior methicillin-resistant S. aureus colonization as a predic

70 In our study, prior methicillin-resistant S. aureus colonization as ascertai

71 ator-associated pneumonia and 54 (13.9%) had methicillin-resistant S. aureus colonization documented

72 f once weekly active surveillance culture of methicillin-resistant S. aureus colonization in predicti

73 Methicillin-resistant S. aureus colonization is associat

74 A significant per year increase in methicillin-resistant S. aureus colonization was also no

75 there has been an increase in the number of methicillin-resistant S. aureus community-acquired infec

76 onia and may decrease the need for empirical methicillin-resistant S. aureus coverage in patients wit

77 rulence of the emerging community-associated methicillin-resistant S. aureus depends on phenol-solubl

78 As the burden of community-acquired methicillin-resistant S. aureus disease continues to inc

79 isolates of interest including MDROs such as methicillin-resistant S. aureus, extended-spectrum beta-

80 s able to rapidly identify and differentiate methicillin-resistant S. aureus from methicillin-suscept

81 cus aureus (MRSA) strains: hospital-acquired methicillin resistant S. aureus (HA-MRSA) and community-

82 s aureus (CA-MRSA) and healthcare-associated methicillin-resistant S. aureus (HA-MRSA) strains and th

83 Methicillin-resistant S. aureus had the highest mortalit

84 gence and rapid spread of community-acquired methicillin-resistant S. aureus has prompted a change in

85 epidemiology and clinical manifestations of methicillin-resistant S. aureus have undergone important

86 s also changing with some community-acquired methicillin-resistant S. aureus having resistance patter

87 of 261 isolates form a multicenter study of methicillin-resistant S. aureus in New York City (NYC) w

88 vanDx, Woburn, MA, USA) for the detection of methicillin-resistant S. aureus in positive blood cultur

89 itially inappropriate antibiotic therapy for methicillin-resistant S. aureus increases the risk for m

90 tive strategy for reducing the prevalence of methicillin-resistant S. aureus infection and eliminatin

91 f associated infections during ICU stay, and methicillin-resistant S. aureus infection develops in on

92 The prevalence of methicillin-resistant S. aureus infection fell from 2.66

93 jects were followed for the development of a methicillin-resistant S. aureus infection for 60 days or

94 r tuning the innate immune response to treat methicillin-resistant S. aureus infection in immunodefic

95 strategies could decrease the prevalence of methicillin-resistant S. aureus infection in the ICU, wi

96 lonization who are at very elevated risk for methicillin-resistant S. aureus infection.

97 ranofin was efficacious in a murine model of methicillin-resistant S. aureus infection.

98 In studies that included only methicillin-resistant S aureus infections (n = 7232), th

99 es are justified by associated reductions in methicillin-resistant S aureus infections and improvemen

100 In 17,738 evaluable patients, methicillin-resistant S. aureus infections (4.1%; 95% CI

101 tent use of beta-lactam antibiotics to treat methicillin-resistant S. aureus infections may contribut

102 Methicillin-resistant S. aureus infections occurred in s

103 techniques might reduce the burden of severe methicillin-resistant S. aureus infections.

104 by drug-resistant strains, designated MRSA (methicillin-resistant S. aureus), is associated with fai

105 The culture of pus yielded a methicillin-resistant S. aureus isolate and the molecula

106 ain LAC, a well-studied community-associated methicillin-resistant S. aureus isolate.

107 y, we found that 56% of surveyed bloodstream methicillin-resistant S. aureus isolates (n = 148) at ou

108 h a set of 59 methicillin-susceptible and 44 methicillin-resistant S. aureus isolates from community-

109 Methicillin-resistant S. aureus isolates in this study s

110 rulent methicillin-susceptible S. aureus and methicillin-resistant S. aureus isolates now circulating

111 In contrast, methicillin-resistant S. aureus isolates were distribute

112 usceptible Staphylococcus aureus, 4/15 (27%) methicillin-resistant S. aureus isolates, 3/16 (19%) met

113 96% of the S. aureus isolates including all methicillin-resistant S. aureus isolates.

114 thicker extracellular matrixes than control methicillin-resistant S. aureus isolates.

115 ed the toxicity and adhesiveness of 90 MRSA (methicillin resistant S. aureus) isolates and found that

116 With the epidemic spread of methicillin-resistant S. aureus, many cases of staphyloc

117 organisms, both 0.25 microg/mL) than against methicillin-resistant S. aureus (MIC(50) and MIC(90), bo

118 We report that methicillin resistant S. aureus (MRSA) is sensitized to

119 illinase resistant ss-lactams (methicillin), methicillin resistant S. aureus (MRSA) strains were iden

120 Methicillin-resistant S aureus (MRSA) accounted for 4 of

121 were nasal carriers, 70% of the carriers had methicillin-resistant S aureus (MRSA), 15% had methicill

122 and 142 cases (13.2%) of the infections were methicillin-resistant S aureus (MRSA).

123 A total of 39% of patients with methicillin-resistant S. aureus (MRSA) (n = 860) and 23%

124 The regional rate of methicillin-resistant S. aureus (MRSA) abscesses may ref

125 FLP patterns were found among 85 isolates of methicillin-resistant S. aureus (MRSA) and 10 propagatin

126 icillin-sensitive S. aureus (MSSA), 207 were methicillin-resistant S. aureus (MRSA) and 27 were borde

127 t-extremity junction (MREJ) region among 907 methicillin-resistant S. aureus (MRSA) and 900 methicill

128 ential as a single or combined treatment for methicillin-resistant S. aureus (MRSA) and anthrax infec

129 115 and E. coli O157:H7), clinical isolates (methicillin-resistant S. aureus (MRSA) and Candida albic

130 SSA), only one dimer was more potent against methicillin-resistant S. aureus (MRSA) and glycopeptide-

131 te signal count ratio (GSCR), differentiated methicillin-resistant S. aureus (MRSA) and methicillin-s

132 f skin infection to compare the virulence of methicillin-resistant S. aureus (MRSA) and methicillin-s

133 and set7) of 61 well-characterized clinical methicillin-resistant S. aureus (MRSA) and methicillin-s

134 ed with CAP, we calculated the prevalence of methicillin-resistant S. aureus (MRSA) and methicillin-s

135 Among methicillin-resistant S. aureus (MRSA) and methicillin-s

136 cal presentations and outcomes of lukF-PV(+) methicillin-resistant S. aureus (MRSA) and MSSA SSTIs we

137 e bacterium Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA) and vancomycin-re

138 nd Prevention (CDC) and others reported that methicillin-resistant S. aureus (MRSA) are significant c

139 A high incidence of methicillin-resistant S. aureus (MRSA) bacteremia cases

140 reenings were done in parallel for 485 saved methicillin-resistant S. aureus (MRSA) blood isolates ac

141 hicillin-susceptible S. aureus (MSSA) and HO methicillin-resistant S. aureus (MRSA) BSIs for 2009-201

142 We determined the surface proteome of methicillin-resistant S. aureus (MRSA) clone usa300 deri

143 thwest Pacific clone [a community-associated methicillin-resistant S. aureus (MRSA) clone], and conte

144 While the prevalence of methicillin-resistant S. aureus (MRSA) continues to incr

145 explored whether whole-genome maps (WGMs) of methicillin-resistant S. aureus (MRSA) could be used to

146 methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) from 300 positive

147 mpared recovery of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) from nasal and gr

148 were infected with an isolate of the USA300 methicillin-resistant S. aureus (MRSA) genetic backgroun

149 nly two cases of empyema necessitatis due to methicillin-resistant S. aureus (MRSA) have been reporte

150 Virulent strains of methicillin-resistant S. aureus (MRSA) have emerged in t

151 ic basis of agr dysfunction among nosocomial methicillin-resistant S. aureus (MRSA) in an area of MRS

152 llin-sensitive S. aureus, with expansion for methicillin-resistant S. aureus (MRSA) in cases of cellu

153 ed B and T cell-dependent protection against methicillin-resistant S. aureus (MRSA) in mice.

154 ole in Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA) induced peritonit

155 Although methicillin-resistant S. aureus (MRSA) infection has bec

156 that are used or their ability to eliminate methicillin-resistant S. aureus (MRSA) infection.

157 7 cells compared with nondiabetic mice after methicillin-resistant S. aureus (MRSA) infection.

158 Staphylococcus aureus (COSA) infections and methicillin-resistant S. aureus (MRSA) infections in 4 C

159 associated with epidemic community-acquired methicillin-resistant S. aureus (MRSA) infections, displ

160 usceptible S. aureus (MSSA) and 73 (17%) had methicillin-resistant S. aureus (MRSA) infections.

161 le (TMP-SMZ) is an alternative treatment for methicillin-resistant S. aureus (MRSA) infections.

162 a multinational collection of isolates from methicillin-resistant S. aureus (MRSA) infective endocar

163 Methicillin-resistant S. aureus (MRSA) is a leading heal

164 Methicillin-resistant S. aureus (MRSA) is a potential bl

165 an S. aureus infection were infected with a methicillin-resistant S. aureus (MRSA) isolate.

166 n readily differentiated EMRSA-15 from other methicillin-resistant S. aureus (MRSA) isolates and also

167 with the most prevalent allelic profile were methicillin-resistant S. aureus (MRSA) isolates and had

168 susceptible Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) isolates recovere

169 evalent clone of 12 geographically dispersed methicillin-resistant S. aureus (MRSA) isolates was iden

170 All 44 (49%) methicillin-resistant S. aureus (MRSA) isolates were fro

171 The literature has shown that methicillin-resistant S. aureus (MRSA) isolates which ar

172 1 December 2006), performed SCCmec typing of methicillin-resistant S. aureus (MRSA) isolates, and str

173 t 250 S. aureus strains tested including 120 methicillin-resistant S. aureus (MRSA) isolates.

174 MLVA did not differentiate community methicillin-resistant S. aureus (MRSA) lineages (USA300,

175 Vancomycin failed to reduce methicillin-resistant S. aureus (MRSA) or methicillin-su

176 preoperative nares screens were positive for methicillin-resistant S. aureus (MRSA) or methicillin-su

177 Staphylococcus aureus (MSSA) organisms, 154 methicillin-resistant S. aureus (MRSA) organisms, and 20

178 ence determinant that may potentially impact methicillin-resistant S. aureus (MRSA) persistence in su

179 Methicillin-resistant S. aureus (MRSA) poses a significa

180 re, we studied a well-characterized clinical methicillin-resistant S. aureus (MRSA) strain (MW2), its

181 wed that the pknB gene (also called stk1) of methicillin-resistant S. aureus (MRSA) strain COL and th

182 tant S. aureus (VRSA) strain HIP11714 to the methicillin-resistant S. aureus (MRSA) strain COL for wh

183 Whole-genome analysis of a methicillin-resistant S. aureus (MRSA) strain USA500 rev

184 eta-lactam resistance in community-acquired, methicillin-resistant S. aureus (MRSA) strains but not i

185 The common USA300 methicillin-resistant S. aureus (MRSA) strains express a

186 We also demonstrate that clinically relevant methicillin-resistant S. aureus (MRSA) strains respond t

187 f recurring SSSI due to S. aureus, including methicillin-resistant S. aureus (MRSA) strains, despite

188 f arlRS does not play a role in autolysis of methicillin-resistant S. aureus (MRSA) strains, such as

189 ecurring SSSI due to S. aureus, particularly methicillin-resistant S. aureus (MRSA) strains, suggests

190 bidity are attributed to the rapid spread of methicillin-resistant S. aureus (MRSA) strains, which ar

191 nt mutant in the epidemic community-acquired methicillin-resistant S. aureus (MRSA) USA300 clone to s

192 he host response to pulmonary infection with methicillin-resistant S. aureus (MRSA) USA300.

193 Methicillin-resistant S. aureus (MRSA) was endemic in ho

194 the skin wounds were infected by S. aureus: methicillin-resistant S. aureus (MRSA) was recovered fro

195 FLGDEC (DD) that can recognize S. aureus and methicillin-resistant S. aureus (MRSA) was used as the r

196 trated that Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), and coagulase-ne

197 ively potentiates beta-lactam antibiotics in methicillin-resistant S. aureus (MRSA), and re-sensitize

198 a dramatic increase in community-associated methicillin-resistant S. aureus (MRSA), but recent repor

199 ection with Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), is a serious con

200 microbes was tested with the same approach: methicillin-resistant S. aureus (MRSA), multidrug-resist

201 nasal swab which was analyzed for S. aureus, methicillin-resistant S. aureus (MRSA), multidrug-resist

202 sence of Staphylococcus aureus, specifically methicillin-resistant S. aureus (MRSA), on retail meat p

203 en, Staphylococcus aureus, and in particular methicillin-resistant S. aureus (MRSA), one of the leadi

204 MICs < 1 mug/mL were achieved against methicillin-resistant S. aureus (MRSA), S. pneumoniae, a

205 of antibiotic-resistant strains, designated methicillin-resistant S. aureus (MRSA), staphylococcal B

206 er baumannii (PDRAB), Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Streptococcus py

207 Outcomes included carriage of S. aureus, methicillin-resistant S. aureus (MRSA), tetracycline-res

208 al tests for the detection of mecC-harboring methicillin-resistant S. aureus (MRSA), which failed to

209 /449 [66.4%]), of which 74.8% (223/298) were methicillin-resistant S. aureus (MRSA).

210 ence of antibiotic-resistant strains such as methicillin-resistant S. aureus (MRSA).

211 ents biofilm formation by S. epidermidis and methicillin-resistant S. aureus (MRSA).

212 ics, with the resultant strain designated as methicillin-resistant S. aureus (MRSA).

213 se infections caused by community-associated methicillin-resistant S. aureus (MRSA).

214 ed the mecA gene for PBP2a are designated as methicillin-resistant S. aureus (MRSA).

215 y 16 (6.3%) of the isolates were found to be methicillin-resistant S. aureus (MRSA).

216 the most frequent invasive infection due to methicillin-resistant S. aureus (MRSA).

217 methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA).

218 ainst S. aureus TMK and 2 mug/mL MIC against methicillin-resistant S. aureus (MRSA).

219 n and skin structure infection (SSSI) due to methicillin-resistant S. aureus (MRSA).

220 dmission (16.7%); 59 (5.3%) patients carried methicillin-resistant S. aureus (MRSA).

221 concomitantly colonized with virulent USA300 methicillin-resistant S. aureus (MRSA).

222 ic wounds such as P.aeruginosa, S.aureus and Methicillin-resistant S.aureus (MRSA) are mediated via t

223 A total of 287 isolates (173 methicillin-resistant S. aureus [MRSA] and 114 methicill

224 hundred seventy-nine S. aureus isolates (125 methicillin-resistant S. aureus [MRSA] and 254 methicill

225 occus aureus collected from U.S. (53.8% were methicillin-resistant S. aureus [MRSA]) and Canadian (46

226 e emergence of antibiotic-resistant strains (methicillin-resistant S. aureus [MRSA]) has prompted res

227 141 methicillin-susceptible S. aureus and 89 methicillin-resistant S. aureus [MRSA]) were analyzed.

228 .1%) had zone sizes of </=17 mm (all 105 had methicillin-resistant S. aureus [MRSA]), 18 (6.5%) had z

229 ptible Staphylococcus aureus [MSSA] and 6.3% methicillin-resistant S. aureus [MRSA]), and hand carria

230 entiates between methicillin-susceptible and methicillin-resistant S. aureus (MSSA and MRSA, respecti

231 the agr regulon in the community-associated methicillin-resistant S. aureus MW2 considerably differe

232 Methicillin-resistant S. aureus nasal carriage had a hig

233 ation vs. one of 171 (0.6%) subjects without methicillin-resistant S. aureus nasal colonization (p <

234 patients provided an estimated prevalence of methicillin-resistant S. aureus nasal colonization at ad

235 of interest were the prevalence estimate of methicillin-resistant S. aureus nasal colonization at ad

236 ccurred in seven of 29 (24.1%) subjects with methicillin-resistant S. aureus nasal colonization vs. o

237 recovered in 15 of 29 (51.7%) subjects with methicillin-resistant S. aureus nasal colonization vs. t

238 n be used to rapidly recognize patients with methicillin-resistant S. aureus nasal colonization who a

239 ng drinks like tea have been found to reduce methicillin-resistant S. aureus nasal colonization.

240 Overall 29 of 200 (14.5%) were found to have methicillin-resistant S. aureus nasal colonization.

241 l colonization vs. two of 171 (1.2%) without methicillin-resistant S. aureus nasal colonization.

242 pated transfer of vancomycin resistance to a methicillin-resistant S. aureus occurred in vivo by inte

243 Methicillin-resistant S. aureus occurred with similar fr

244 CAP was associated with an increased risk of methicillin-resistant S. aureus (odds ratio [OR], 4.72;

245 n-susceptible S. aureus was detected but not methicillin-resistant S. aureus or S. pyogenes from cell

246 nterval [CI], 2.24 to 92.55), infection with methicillin-resistant S. aureus (OR, 9.3; 95% CI, 1.45 t

247 XpressFISH assay, which detected 209 of 211 methicillin-resistant S. aureus organisms (sensitivity,

248 ceptible to oxacillin (oxacillin-susceptible methicillin-resistant S. aureus [OS-MRSA]).

249 specialized ICUs populations and reports on methicillin-resistant S. aureus outbreaks were excluded.

250 phylococcus aureus (p = 0.007), particularly methicillin-resistant S. aureus (p < 0.0001).

251 weeks of vancomycin treatment for recurrent methicillin-resistant S. aureus peritonitis associated w

252 innate immune response in a murine model of methicillin-resistant S. aureus pneumonia.

253 tivity permits detection of genomic DNA from methicillin-resistant S. aureus positive blood cultures

254 s study calculates the cost-effectiveness of methicillin-resistant S aureus prevention strategies and

255 to determine if the implementation costs of methicillin-resistant S aureus prevention strategies are

256 itially inappropriate antibiotic therapy for methicillin-resistant S. aureus prolongs length of stay

257 showed a genetic similarity to PVL-positive, methicillin-resistant S. aureus (PVL-MRSA) strains, alth

258 episodes with 90-day follow-up, excluding 5 methicillin-resistant S. aureus SAB cases.

259 d "sporadic." The most prevalent lineage was methicillin-resistant S. aureus (SAL 4).

260 develop a murine model of community-acquired methicillin-resistant S. aureus SSTI (CA-MRSA SSTI) that

261 tailed description of a community-associated methicillin-resistant S. aureus ST80 orbital cellulitis

262 ntified patients admitted with nonnosocomial methicillin-resistant S. aureus sterile-site infections

263 itially inappropriate antibiotic therapy for methicillin-resistant S. aureus sterile-site infections

264 Methicillin-resistant S. aureus strain 301 (MRSA 301) or

265 A USA300 community-associated methicillin-resistant S. aureus strain deficient in Rot

266 Also, inactivation of LyrA in a methicillin-resistant S. aureus strain did not precipita

267 n of the pbp2 gene did not block growth of a methicillin-resistant S. aureus strain expressing the ex

268 re found to be active against vancomycin and methicillin-resistant S. aureus strain with appreciable

269 Methicillin-resistant S aureus strains concordant with i

270 l health threat because of the prevalence of methicillin-resistant S. aureus strains (MRSA).

271 hyococcus aureus and especially the epidemic methicillin-resistant S. aureus strains cause severe nec

272 Most methicillin-resistant S. aureus strains causing bacterem

273 ain MW2 (USA400 lineage) and other community methicillin-resistant S. aureus strains most commonly ca

274 ar effects of PVL using community-associated methicillin-resistant S. aureus strains, we found no sig

275 athogenicity factors of community-associated methicillin-resistant S. aureus strains.

276 Newer agents active against methicillin-resistant S. aureus such as linezolid have b

277 m the nares of 6 of 32 infants surveyed in a methicillin-resistant S. aureus surveillance program, an

278 This review of the changing epidemiology of methicillin-resistant S. aureus, the emergence of vancom

279 on, the tibias of rabbits were infected with methicillin-resistant S. aureus to produce chronic osteo

280 Methicillin-resistant S. aureus treated with plicatamide

281 Community-acquired methicillin-resistant S. aureus used to be predominantly

282 tibiotic-resistant strains tested, including methicillin-resistant S. aureus, vancomycin-intermediate

283 nt S. aureus colonization as a predictor for methicillin-resistant S. aureus ventilator-associated pn

284 olonization in predicting the development of methicillin-resistant S. aureus ventilator-associated pn

285 Of the 388 patients, 37 (9.5%) had methicillin-resistant S. aureus ventilator-associated pn

286 Methicillin-resistant S aureus was recovered from sample

287 After we controlled for confounding factors, methicillin-resistant S. aureus was associated with the

288 A clinical isolate of methicillin-resistant S. aureus was killed by platelets

289 Methicillin-resistant S. aureus was not found by culture

290 Nasal cultures for methicillin-resistant S. aureus were performed on all su

291 reus, methicillin-susceptible S. aureus, and methicillin-resistant S. aureus with sensitivities of 10